The nearly $1 billion won by VirnetX in patent trials against Apple Inc. exists under a cloud since the Patent Trial and Appeal Board has found the patents invalid. With appeals pending from the board's decisions and one of the trials, here's a look at VirnetX's arguments that the patents shouldn't have been reviewed, and Apple's efforts to flip the verdict.
Duke University has sued drug maker Elan Corp. over competing patents for a promising obesity drug.
European governments are questioning the voting process that led to the passage of a European Union law on software patents in May.
Gateway has filed a complaint with the U.S. International Trade Commission, seeking to ban rival Hewlett-Packard from importing certain computers, monitors and the components used to make them.
Mylan Laboratories has agreed to pay $9 million to Tapestry Pharmaceuticals Inc. and Australia-based Mayne Group Ltd's U.S. unit to settle a patent lawsuit over the cancer treatment paclitaxel.
Chinese authorities are cooperating with European regulators and experts to revamp the country’s copyright system.
King & Spalding has picked up yet another intellectual property litigator from a rival, as the firm continues its aggressive expansion of its newly established New York City patent litigation practice.
Eye-care maker CooperVision Inc. on Monday lambasted rival CIBA Vision Corp. for trying to strike a witness from the ongoing litigation between the two over various contact lens patents.
Both Qualcomm and Texas Instruments declared victory after a Delaware Court ruled that TI violated an agreement with Qualcomm but that Qualcomm is not entitled to break off the deal.
England’s highest court, the House of Lords, will hear the long-running patent dispute between Amgen and Transkaryotic Therapies/Hoechst over the blockbuster blood booster hormone erythropoietin (epo) next week.
The U.S. Court of Appeals for the Federal Circuit has dismissed an appeal by the University of Illinois that sought a shield of sovereign immunity from counterclaims filed by Japanese electronics maker Fujitsu in a lawsuit over patents for plasma displays.
Alain Pompidou has succeeded Ingo Kober as President of the European Patent Office, taking office as part of an unusual “dual-mandate” deal that was negotiated to quell a row between member states over the appointment.
The Supreme Court of Canada has ruled that internet service providers cannot be held accountable for digital music files transmitted over their networks, dealing a blow to the music industry’s anti-piracy efforts.
Mylan Laboratories has supplemented a petition with the FDA, seeking an immediate response to its claim that branded drugmakers are unfairly undermining sales of generic drugmakers.
A U.S. district court has cleared Barr Laboratories of infringing three patents at the center of the generic drug maker’s challenge involving Aventis’ Allegra blockbuster allergy drug.
A federal judge has dismissed biotech company Promega Corp.'s lawsuit in a long-running legal battle against rival Hoffmann LaRoche and its partner, Applera Corp, but Promega two weeks to provide additional details in an amended lawsuit.
California start-up Affinity Engines has sued Google for theft of trade secrets, alleging that a former employee stole code to create Google's social-networking site Orkut.com.
The European Patent Organization has made plans to establish an academy for training and education benefiting the European Patent System.
A former employee of Japanese consumer electronics maker Sharp has filed a $4.6 million lawsuit against the company over liquid crystal displays patents.
Western Digital has joined Seagate Technology in suing rival microdrive disk manufacturer Cornice for patent infringement.
A U.S. district court judge has ruled that Pfizer’s patents for Accupril are valid, dealing Israeli drug maker Teva a blow in its efforts to market a generic version of the $600 million blood pressure medicine.